EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

Nature Medicine

Volumn 18, Issue 9, 2012, Pages 1418-1422

  Van Hoecke, Annelies ^a,b   Schoonaert, Lies ^a,b   Lemmens, Robin ^a,b,c   Timmers, Mieke ^a,b   Staats, Kim A ^a,b   Laird, Angela S ^d   Peeters, Elke ^c   Philips, Thomas ^a,b   Goris, An ^b   Dubois, Bénédicte ^b,c   Andersen, Peter M ^e   Al Chalabi, Ammar ^f   Thijs, Vincent ^a,c   Turnley, Ann M ^g   Van Vught, Paul W ^h   Veldink, Jan H ^h   Hardiman, Orla ⁱ   Van Den Bosch, Ludo ^a,b   Gonzalez Perez, Paloma ^j   Van Damme, Philip ^a,b,c   Brown Jr , Robert H ^j   Van Den Berg, Leonard H ^h   Robberecht, Wim ^a,b,c   more..

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UMEÅ UNIVERSITY   (Sweden)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ TRINITY COLLEGE DUBLIN   (Ireland)

^j UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN A4; TAR DNA BINDING PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; EPHRIN RECEPTOR A4; MORPHOLINO OLIGONUCLEOTIDE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; MALE; MOTONEURON; MOUSE; NEUROPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RODENT; SURVIVAL; ZEBRA FISH; ANALYSIS OF VARIANCE; ANIMAL; DNA SEQUENCE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; NONPARAMETRIC TEST; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; ROTAROD TEST; SIGNAL TRANSDUCTION;

ANIMALIA; DANIO RERIO; RATTUS; RODENTIA;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANIMALS; BASE SEQUENCE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MORPHOLINOS; MOTOR NEURONS; PHENOTYPE; RATS; RECEPTOR, EPHA4; ROTAROD PERFORMANCE TEST; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE; ZEBRAFISH;

EID: 84868656581     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2901     Document Type: Article

References (38)

1. Rosen, D.R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993).
2. DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256 (2011).
3. Renton, A.E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268 (2011).
4. Penco, S. et al. Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease. J. Mol. Neurosci. 44, 25-30 (2011).
5. Kim, W. et al. Anticipation and phenotypic heterogeneity in Korean familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation. J. Clin. Neurol. 3, 38-44 (2007).
6. Fogh, I. et al. Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality. Neurogenetics 8, 235-236 (2007).
7. Lemmens, R. et al. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum. Mol. Genet. 16, 2359-2365 (2007).
8. Laird, A.S. et al. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS ONE 5, e13368 (2010).
9. Cooke, J.E., Kemp, H.A. & Moens, C.B. EphA4 is required for cell adhesion and rhombomere-boundary formation in the zebrafish. Curr. Biol. 15, 536-542 (2005).
10. Xu, Q., Alldus, G., Holder, N. & Wilkinson, D.G. Expression of truncated Sek-1 receptor tyrosine kinase disrupts the segmental restriction of gene expression in the Xenopus and zebrafish hindbrain. Development 121, 4005-4016 (1995).
11. Klein, R. Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat. Neurosci. 12, 15-20 (2009).
12. Dottori, M. et al. EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract. Proc. Natl. Acad. Sci. USA 95, 13248-13253 (1998).
13. Kullander, K. et al. Role of EphA4 and EphrinB3 in local neuronal circuits that control walking. Science 299, 1889-1892 (2003).
14. Noberini, R. et al. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J. Biol. Chem. 283, 29461-29472 (2008).
15. Goldshmit, Y., Galea, M.P., Wise, G., Bartlett, P.F. & Turnley, A.M. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J. Neurosci. 24, 10064-10073 (2004).
16. Fabes, J., Anderson, P., Brennan, C. & Bolsover, S. Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord. Eur. J. Neurosci. 26, 2496-2505 (2007).
17. Goldshmit, Y. et al. EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice. PLoS ONE 6, e24636 (2011).
18. Filosa, A. et al. Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. Nat. Neurosci. 12, 1285-1292 (2009).
19. Rothstein, J.D., Martin, L.J. & Kuncl, R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468 (1992).
20. Rothstein, J.D., Van Kammen, M., Levey, A.I., Martin, L.J. & Kuncl, R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84 (1995).
21. Rothstein, J.D. et al. β-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73-77 (2005).
22. Bakels, R. & Kernell, D. Matching between motoneurone and muscle unit properties in rat medial gastrocnemius. J. Physiol. (Lond.) 463, 307-324 (1993).
23. Gardiner, P.F. Physiological properties of motoneurons innervating different muscle unit types in rat gastrocnemius. J. Neurophysiol. 69, 1160-1170 (1993).
24. Frey, D. et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20, 2534-2542 (2000).
25. Pun, S., Santos, A.F., Saxena, S., Xu, L. & Caroni, P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9, 408-419 (2006).
26. Maes, O.C. et al. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging 28, 1795-1809 (2007).
27. Borovecki, F. et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc. Natl. Acad. Sci. USA 102, 11023-11028 (2005).
28. Gladkevich, A., Kauffman, H.F. & Korf, J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 559-576 (2004).
29. Glatt, S.J. et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc. Natl. Acad. Sci. USA 102, 15533-15538 (2005).
30. Matigian, N.A. et al. Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS ONE 3, e2412 (2008).
31. Tsuang, M.T. et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 133B, 1-5 (2005).
32. Fu, J. et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet. 8, e1002431 (2012).
33. Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672 (2008).
34. Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133 (2006).
35. Gitcho, M.A. et al. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 63, 535-538 (2008).
36. McWhorter, M.L., Monani, U.R., Burghes, A.H. & Beattie, C.E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919-931 (2003).
37. Storkebaum, E. et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8, 85-92 (2005).
38. Cashman, N.R. et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194, 209-221 (1992).